19 June 2013
Keywords: crucell, dsm, mab, deal, gsk, dutch, biotechnology
Article | 23 August 2004
Dutch biotechnology company Crucell NV and allied contract manufacturerDSM Biologics have announced the signing of a PER.C6 research license
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 August 2004
16 August 2004
18 June 2013
© 2013 thepharmaletter.com